Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients

NCT00865579 is registered in ClinicalTrials.gov with Newron Pharmaceuticals SPA as lead sponsor.

NCT NCT00865579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00865579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Lead sponsor
Newron Pharmaceuticals SPA
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2009
Completion date
June 30, 2012
Enrollment
964 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease